Know Cancer

or
forgot password

Screening and Risk Communication for First Degree Relatives of Colorectal Cancer Patients


N/A
N/A
60 Years
Open (Enrolling)
Both
Colorectal Cancer

Thank you

Trial Information

Screening and Risk Communication for First Degree Relatives of Colorectal Cancer Patients


You will be interviewed by a member of the study staff over the telephone. You will be
asked about your awareness of screening tests for colorectal cancer, and your attitudes
toward colorectal cancer screening. You also will also be asked about your family's past
use of these screening tests, and how you discuss colorectal cancer risk and screening with
your family and health care providers. Some demographic information also will be collected
(such as your age or marital status). The questionnaire will take between 30 and 45 minutes
to complete.

Your answers to the questions and your personal information will be kept strictly
confidential. Your questionnaire answers will be identified with a code number, rather than
a name, so that you cannot be identified.

This is an investigational study. Up to 325 colorectal cancer patients and their close
relatives may take part in the study. All will be enrolled MD Anderson.


Inclusion Criteria:



1. Colorectal cancer (CRC) Patients: CRC patients will be eligible if they:

- have a diagnosis of colorectal adenocarcinoma at or before age 60, and were
diagnosed between 6 and 12 months prior to being contacted about this study (to
allow adequate time for dissemination of CRC risk to family members, and to
avoid interference with care surrounding the initial diagnosis);

- have at least one living FDR age 40 years or older;

- can read and speak English.

2. FDRs of CRC Patients: FDRs will be eligible if they

- are age 40 years or older;

- can read and speak English.

Exclusion Criteria:

1. CRC Patients: CRC patients will be excluded if they:

- have a history of a known hereditary CRC syndrome (e.g., HNPCC, familial
polyposis) or inflammatory bowel disease (e.g., ulcerative colitis or Crohn's
disease); or

- have an ECOG PS>1.

2. FDRs of CRC patients: FDRs will be excluded if they:

- have a history of a known hereditary CRC syndrome (e.g., HNPCC, familial
polyposis) or inflammatory bowel disease (e.g., ulcerative colitis or Crohn's
disease); or

- have a personal history of colon polyps or of cancer diagnosed within 5 years
prior to entry into the study, with the exception of nonmelanoma skin cancer.

Type of Study:

Observational

Study Design:

Observational Model: Family-Based, Time Perspective: Cross-Sectional

Outcome Measure:

Psychosocial + External factors influencing CRC patients' communication with FDRs about CRC risk & screening information

Outcome Time Frame:

2 Years

Safety Issue:

No

Principal Investigator

Susan Peterson, PHD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

M.D. Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

2004-0316

NCT ID:

NCT00632515

Start Date:

January 2008

Completion Date:

Related Keywords:

  • Colorectal Cancer
  • Colorectal Cancer
  • CRC
  • Familial CRC
  • Cancer Screening
  • Questionnaire
  • First Degree Relatives
  • FDRs
  • Risk Communication
  • Colorectal Neoplasms

Name

Location

UT MD Anderson Cancer CenterHouston, Texas  77030